Navigating the Complexities of AML Drug Development: Expert Perspectives

In this engaging session, our expert hematologist and an experienced regulator will come together to discuss the critical challenges and potential solutions in developing drugs for Acute Myeloid Leukemia (AML), with a special focus on relapsed and refractory cases.

Key topics will include:

• Current obstacles in AML drug development
• Regulatory considerations for novel therapies, especially for targeted therapies
• Strategies for improving clinical trial design
• Emerging trends and innovative approaches

Don't miss this unique opportunity to gain valuable insights from both clinical and regulatory viewpoints. Our experts will share their experiences, discuss recent advancements, and explore future directions in AML treatment. 

Whether you're a researcher, clinician, or industry professional, this webinar will provide you with the actionable knowledge to advance AML drug development and improve patient outcomes. 

Register now to be a part of this important conversation!